NTLA icon

Intellia Therapeutics
NTLA

Overview Fund Activity

302 hedge funds and large institutions have $2.69B invested in Intellia Therapeutics in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 119 increasing their positions, 80 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
302
Holders Change
-16
Holders Change %
-5.03%
% of All Funds
4.87%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
49
Increased
119
Reduced
80
Closed
60
Calls
$22.8M
Puts
$11.7M
Net Calls
+$11.1M
Net Calls Change
+$803K

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$69.6M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$272M
3
BlackRock
3
BlackRock
New York
$253M
4
State Street
4
State Street
Massachusetts
$131M
5
Morgan Stanley
5
Morgan Stanley
New York
$87.9M

Top Sellers

1
PHS
1
PFM Health Sciences
California
$0
2
APM
2
Avidity Partners Management
Texas
$22.3M
3
Goldman Sachs
3
Goldman Sachs
New York
$21.9M
4
Millennium Management
4
Millennium Management
New York
$1.75M
5
Connor, Clark & Lunn Investment Management (CC&L)
5
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$23.1M +$760K +21,770 +3%
APM
27
Avidity Partners Management
Texas
$22.3M -$12.6M -360,900 -36%
Goldman Sachs
28
Goldman Sachs
New York
$21.9M -$12.4M -354,661 -36%
Two Sigma Advisers
29
Two Sigma Advisers
New York
$20.3M -$59.3K -1,700 -0.3%
DVF
30
Discovery Value Fund
Singapore
$20M -$402K -11,533 -2%
Nomura Holdings
31
Nomura Holdings
Japan
$19.8M +$13.9M +399,175 +235%
T. Rowe Price Investment Management
32
T. Rowe Price Investment Management
Maryland
$18.6M -$29.7K -852 -0.2%
WP
33
Woodline Partners
California
$17.4M +$5.27M +150,991 +43%
MB
34
MPM BioImpact
Massachusetts
$15.9M +$2.82M +80,829 +22%
Invesco
35
Invesco
Georgia
$14.6M +$464K +13,299 +3%
Ameriprise
36
Ameriprise
Minnesota
$14.3M -$842K -24,154 -6%
UBS AM
37
UBS AM
Illinois
$13.7M -$343K -9,831 -2%
Marshall Wace
38
Marshall Wace
United Kingdom
$13.6M +$13.3M +381,674 +5,158%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$13.2M +$1.28M +36,803 +11%
American Century Companies
40
American Century Companies
Missouri
$11.6M +$2.21M +63,361 +24%
EAM
41
Eventide Asset Management
Massachusetts
$11.1M – – –
CC
42
Casdin Capital
New York
$10.3M – – –
AG
43
Artal Group
Luxembourg
$9.6M – – –
Adage Capital Partners
44
Adage Capital Partners
Massachusetts
$9.18M -$2.16M -62,000 -19%
Barclays
45
Barclays
United Kingdom
$9.07M +$2.63M +75,296 +41%
GCM
46
Ghisallo Capital Management
Massachusetts
$8.72M +$8.72M +250,000 New
Rafferty Asset Management
47
Rafferty Asset Management
New York
$8.18M +$3.66M +104,805 +81%
GIM
48
Granahan Investment Management
Massachusetts
$7.59M +$2.33M +66,788 +44%
Mirae Asset Global Investments
49
Mirae Asset Global Investments
South Korea
$7.27M -$110K -3,152 -1%
Hudson Bay Capital Management
50
Hudson Bay Capital Management
Connecticut
$7.26M +$6.74M +193,100 +1,287%
1
2
3 4 5